Excelsior

Excelsior BioPharma specializes in commercialization of medicines for rare/niche specialty diseases across Taiwan and Southeast Asia. The firm provides end-to-end services from diagnostics to regulatory approval to market execution. It imports/distributes prescription drugs and medical devices; develops new drugs through internal R&D; operates GMP-certified manufacturing facilities; collaborates with academic institutions on genetic/metabolic disorder diagnostics; maintains an active pipeline focused on rare disease innovation; has received multiple certifications from Taiwan FDA including PIC/S GMP/GDP compliance. Its product portfolio spans prescription medicines (e.g., OMACOR®), diagnostic kits ("Actim"), oral care products ("Oral7"), healthcare foods/cosmetics. The group includes subsidiaries focused on manufacturing/R&D in both Taiwan and Malaysia.